Clinical Utility of Minimal Residual Disease Measurements in the Context of Therapy in Childhood ALL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Utility of Sequential Minimal Residual Disease Measurements in the Context of Risk-Based Therapy in Childhood Acute Lymphoblastic Leukaemia: A Prospective Study
Lancet Oncol 2015 Mar 19;[EPub Ahead of Print], CH Pui, D Pei, E Coustan-Smith, S Jeha, C Cheng, WP Bowman, JT Sandlund, RC Ribeiro, JE Rubnitz, H Inaba, D Bhojwani, TA Gruber, WH Leung, JR Downing, WE Evans, MV Relling, D CampanaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.